Heart muscle disease patients benefit from defibrillator

September 4, 2017, Aston University
Heart muscle disease patients benefit from defibrillator - research
Fitting a defibrillator could benefit patients undergoing CRT for heart disease. Credit: Aston University

Some heart disease patients who are treated with cardiac resynchronisation therapy (CRT) would live longer and have fewer hospital admissions if they also received a defibrillator, concludes a team of researchers led by Aston Medical School at Aston University.

The device could be beneficial to patients diagnosed with non-ischaemic - chronic disease of the - who also have muscle scars.

The results of the study – Clinical outcomes of Cardiac Resynchronisation Therapy with or without defibrillation in non-ischemic cardiomyopathy: impact of left ventricular midwall fibrosis – were published recently by the Journal of the American College of Cardiology.

Professor Francisco Leyva, Professor of Cardiology at Aston Medical School, led the research and said: "Previous studies have ruled out defibrillators as being beneficial for people undergoing CRT as treatment for cardiomyopathy. However, these studies did not use MRI scans to detect within the muscle of the patient's heart.  

"Our study is the first to use MRI scans to determine whether patients with non-ischaemic cardiomyopathy who have a defibrillator fitted do better than those who are given a pacemaker.

"The findings show that the addition of a defibrillator would be very advantageous to patients who also have heart muscle scar tissue in that they will potentially live longer and will be less likely to be admitted to hospital for heart failure or other cardiac problems."

The study involved 252 patients with cardiomyopathy from the Queen Elizabeth Hospital and Good Hope Hospital in Birmingham over a period of up to 14 years. Of the 252 patients, 68 also had heart muscle scarring.  

"The findings have implications for the choice of device used to help treat patients with non-ischaemic cardiomyopathy," added Professor Leyva.

"We are recommending that defibrillators should be added to patients with cardiomyopathy with heart muscle scars who are being treated with cardiac resynchronisation therapy."

CRT is an implanted device that co-ordinates the contractions between the heart's left and right ventricles, while an implanted defibrillator helps to control life-threatening arrhythmias, or irregular heartbeats, that might lead to .

In cardiomyopathy, the heart muscle becomes enlarged or thickens and in some cases tissue is replaced with scar tissue. As the disease progresses, the heart grows weaker and less able to pump blood around the body and maintain normal electrical rhythm. This can lead to heart failure, and complications including a build-up of fluid in the body and heart valve problems.

Cardiomyopathy affects people of all ages and there are numerous causes including it being genetic or as a result of other health conditions and diseases.

Treatment includes lifestyle changes, drug therapy, surgery and implanted devices.

Explore further: Adding defibrillator to CRT no benefit in dilated cardiomyopathy

More information: Francisco Leyva et al. Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy, Journal of the American College of Cardiology (2017). DOI: 10.1016/j.jacc.2017.07.712

Related Stories

Adding defibrillator to CRT no benefit in dilated cardiomyopathy

April 3, 2017
(HealthDay)—For patients with heart failure with indications for cardiac resynchronization therapy (CRT), those with ischemic cardiomyopathy (ICM), but not those with nonischemic dilated cardiomyopathy (DCM), benefit from ...

Hypertrophic cardiomyopathy may not cause symptoms until later in life

May 6, 2016
Dear Mayo Clinic: My dad was diagnosed with hypertrophic cardiomyopathy at age 52. He has been on medication for a few months, but doctors said he likely will need surgery, even though his symptoms are very mild. Is surgery ...

Stem cell-sheet transplantation feasible in cardiomyopathy

April 6, 2017
(HealthDay)—Stem cell-sheet transplantation shows promise in the treatment of cardiomyopathy, according to research published online April 5 in the Journal of the American Heart Association.

Even mild heart failure can lead to sudden death

February 16, 2015
Sudden cardiac arrest is a possible cause of death in patients with non-ischaemic cardiac muscle weakness, i.e. a type of heart failure caused by genetics or for which no cause is known. Now, researchers at the University ...

Scarring of heart muscle linked with increased risk of death in patients with type of cardiomyopathy

March 5, 2013
Detection of midwall fibrosis (the presence of scar tissue in the middle of the heart muscle wall) via magnetic resonance imaging among patients with nonischemic dilated cardiomyopathy (a condition affecting the heart muscle) ...

Stopping drug abuse can reverse related heart damage

May 29, 2017
Quitting methamphetamine use can reverse the damage the drug causes to the heart and improve heart function in abusers when combined with appropriate medical treatment, potentially preventing future drug-related cases of ...

Recommended for you

Proteins cooperate to break up energy structures in oxygen starved heart cells

November 19, 2018
During a heart attack, the supply of oxygen to heart cells is decreased. This reduced oxygen level, called hypoxia, causes the cell's powerhouses, the mitochondria, to fragment, impairing cell function and leading to heart ...

Bullying and violence at work increases the risk of cardiovascular disease

November 19, 2018
People who are bullied at work or experience violence at work are at higher risk of heart and brain blood vessel problems, including heart attacks and stroke, according to the largest prospective study to investigate the ...

Genetic analysis links obesity with diabetes, coronary artery disease

November 16, 2018
A Cleveland Clinic genetic analysis has found that obesity itself, not just the adverse health effects associated with it, significantly increases the risk of Type 2 diabetes and coronary artery disease. The paper was published ...

Non-coding genetic variant could improve key vascular functions

November 15, 2018
Atherosclerotic disease, the slow and silent hardening and narrowing of the arteries, is a leading cause of mortality worldwide. It is responsible for more than 15 million deaths each year, including an estimated 610,000 ...

Study of two tribes sheds light on role of Western-influenced diet in blood pressure

November 14, 2018
A South American tribe living in near-total isolation with no Western dietary influences showed no increase in average blood pressure from age one to age 60, according to a study led by researchers at Johns Hopkins Bloomberg ...

Heart failure patients shouldn't stop meds even if condition improves: study

November 13, 2018
(HealthDay)—There's bad news for heart failure patients with dilated cardiomyopathy who'd like to stop taking their meds.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.